![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-desktop-w27gif-57924.gif)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-mobile-w27gif-62411.gif)
X
20
Sioux Pharm, Inc. Sioux Center Us, based in U.S.A, is a pharmaceutical company.
One of their significant offerings is Chondroitin sulfate sodium, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2009-218 - Rev 00
This TSE Type CEP, issued on August 31, 2016, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 2064 associated with this CEP further emphasizes